antiviral therapy Flashcards
Hepatitis C therapy - drugs
- Interferons - α
- ribavirin
- Simeprevir
- Sofosbuvir
Ribavirin - mechanism of action
inhibits synthesis of guanine nucleotides by competitively inhibiting inosine monophophate dehydrogenase
Ribavirin inhibits synthesis of …. by
- guanine nucleotides
- competitively inhibiting inosine monophophate dehydrogenase
Ribavirin - clinical use
- Chronic HCV
2. RSV (palivizumab is preferred in children)
Ribavirin - toxicity
- hemolytic anemia
2. severe teratogen
Simeprevir - mechanism of action
HCV protease inhibitor
prevents viral replication
Simeprevir - clinical use
Chronic HCV in combination with ledipasvir (NS5A inhibitor)
DO NOT USE AS MONOTHERPAY
Simeprevir - toxicity
- photosensitivity reaction
2. rash
Sofosbuvir - mechanism of action
inhibitis HCV RNA-dependent RNA polymerase acting as a chain terminator
Sofosbuvir - clinical use
Chronic HCV in combination with ribavirin +/- peginterferon alfa
DO NOT USE AS MONOTHERAPY
Sofosbuvir - side effects
fatique
headache
nausea
HIV therpay regimen
Highly active antiretrovial therapy (HAART)
HIV therpay - groups of drugs
- protease inhibitors
- Nucleoside Reverse Transcriptase Inhibitor (NRTI)
- Non-nucleoside reverse transcriptase inhibitors (NNRTI)
- Integrase inhibitors
- Fusion inhibitors
HAART - when to start
often initiated at the time of HIV diagnosis
strongeest indication for patients presenting with AIDS-defining illness, low CD4 (under 5 hundreds), or high viral load
HAART regimen consist of
2NRTIs (Nucleoside Reverse Transcriptase Inhibitor) and 1 of the following: NNRT1 (Non-nucleoside reverse transcriptase inhibitors) or protease inhibitor or integrase inhibitor
Protease inhibitors - drugs
-NAVIR